Exploring how early life factors affect heart and metabolic health in young people.
Understanding the Impact of Early Life Factors on Cardiometabolic Risk throughout the Life Course in a Large and Diverse Cohort of Adolescents and Young Adults
This study looks at how things that happen early in life can affect the chances of young people developing health issues like diabetes and high blood pressure, helping us understand who might be at greater risk and how these problems differ from those that show up later in life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11037063 on NIH RePORTER |
What this research studies
This research investigates the impact of early life factors on the risk of developing cardiometabolic conditions, such as diabetes and hypertension, in adolescents and young adults. By analyzing a large and diverse cohort, the study aims to identify high-risk populations and understand how these conditions differ from those that emerge in adulthood. The research will utilize population-based data and objective measures to provide insights into the epidemiology of these health issues, focusing on the critical developmental windows of adolescence and young adulthood.
Who could benefit from this research
Good fit: Ideal candidates for this research include adolescents and young adults, particularly those from diverse racial and ethnic backgrounds who may be at higher risk for cardiometabolic conditions.
Not a fit: Patients who are older adults or those without any risk factors for cardiometabolic conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted prevention strategies that improve heart and metabolic health outcomes for young people.
How similar studies have performed: Previous research has shown that understanding early life factors can significantly impact health outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Kubo, Ai — Kaiser Foundation Research Institute
- Study coordinator: Kubo, Ai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.